CD8A and cancer: However, the fact that SATB1565–574-specific T cell responses are easily induced in healthy donors as well as cancer patients, suggests that a high frequency of SATB1-specific CD8+ T cell precursors is present in the circulation, which indicates that anti-cancer vaccines targeting SATB1 may be safe and may not induce autoimmunity.